在通用医疗保健系统中实施对无塑性甲状腺癌的快速反应途径
Sana Ghaznavi1,2,3, Kiana Mahboubi3,4, Debbie Lamb2
1Department of Medicine, Cumming School of Medicine University of Calgary Calgary Alberta Canada.
Laryngoscope investigative otolaryngology
|February 18, 2026
概括
实施无塑性甲状腺癌快速反应小组 (ARRT) 途径显著减少了无塑性甲状腺癌 (ATC) 患者的诊断和治疗时间. 这种快速反应模型可以改善对侵袭性癌症的护理协调.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医疗保健管理的管理
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种罕见且具有攻击性的恶性瘤,预后不佳.
- 及时诊断和治疗对于改善ATC患者的治疗结果至关重要.
- 现有的医疗保健系统在协调罕见癌症的快速多学科护理方面可能面临挑战.
研究的目的:
- 实施和评估一个多学科的无塑性甲状腺癌快速反应小组 (ARRT) 途径.
- 评估ARRT途径对通用医疗保健系统内的ATC患者诊断和治疗时间表的影响.
主要方法:
- 一项准实验性研究比较了加拿大第三级护理癌症中心的前路径和后路径时期.
- 包括26名已确认有ATC的成年患者 (11名前途,15名后途).
- 该ARRT途径涉及早期鉴定,细胞学快速活检,加速分期和分子分析,当天咨询和早期息护理.
主要成果:
- 该ARRT途径显著减少了从怀疑到分期 (21至6天),多学科评估 (28至8天) 和治疗开始 (29至18天) 的中位时间.
- 途径后的患者表现出快速分子测试 (100%对54%) 和R0/R1切除 (100%对17%) 的改善率.
结论:
- 在通用医疗环境中,ARRT途径有效地减少了ATC患者的诊断和治疗延迟.
- 这种快速反应模型是可行的,并且有效地改善了罕见的,侵略性的恶性瘤的护理协调.
- 该研究提供了一个可复制的框架,用于在全球医疗保健系统中实施类似的途径.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...


